Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

2 terminated/withdrawn out of 12 trials

Success Rate

77.8%

-8.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
10(90.9%)
Phase 1
1(9.1%)
11Total
N/A(10)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT05086523Phase 1Completed

Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study

Role: lead

NCT05345925Not ApplicableCompleted

PV Loops With CNT in Multiple Pacing Sites

Role: lead

NCT04463121Not ApplicableCompleted

Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)

Role: lead

NCT02909868Not ApplicableCompleted

CS-03 Pressure-Volume Loop Sub-study With RV Lead Positioning

Role: lead

NCT03757377Not ApplicableTerminated

Moderato System in Patients With Hypertension

Role: lead

NCT02837445Not ApplicableTerminated

Moderato System: A Double-Blind Randomized Trial Ver 1.1

Role: lead

NCT04573699Completed

Cardiac Neuromodulation for Heart Failure

Role: lead

NCT07598760Not ApplicableNot Yet Recruiting

Clinical Feasibility of Cardiac Neuromodulation Therapy for Heart Failure With Preserved Ejection Fraction

Role: lead

NCT05462405Not ApplicableActive Not Recruiting

Evaluation of Sympathetic Activity Effects by the BackBeat Medical Cardiac Neuromodulation Therapy (CNT).

Role: lead

NCT05719454Not ApplicableRecruiting

Novel Setup Algorithm for Cardiac Neuromodulation Therapy

Role: lead

NCT02282033Not ApplicableCompleted

Safety and Performance Study of the Moderato System

Role: lead

NCT02382484Not ApplicableCompleted

Impact of Pacing Site and AV Delay on Blood Pressure in Hypertensive Patients

Role: lead

All 12 trials loaded